PHAXIAM Therapeutics S.A. (PHXM.PA)
EUR 0.68
(-3.66%)
EUR 0.68
(-3.66%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -23.66 Million EUR | 26.25% |
| 2022 | -32.08 Million EUR | 47.14% |
| 2021 | -60.69 Million EUR | 16.34% |
| 2020 | -72.55 Million EUR | -4.6% |
| 2019 | -69.35 Million EUR | -44.29% |
| 2018 | -48.06 Million EUR | -40.33% |
| 2017 | -34.25 Million EUR | -30.69% |
| 2016 | -26.21 Million EUR | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -5.32 Million EUR | 0.0% |
| 2024 Q1 | -5.32 Million EUR | 3.34% |
| 2023 Q3 | -5.74 Million EUR | 54.65% |
| 2023 Q1 | -4.49 Million EUR | 47.66% |
| 2023 FY | -25.41 Million EUR | 20.78% |
| 2023 Q4 | -5.51 Million EUR | 4.11% |
| 2023 Q2 | -12.67 Million EUR | -182.16% |
| 2022 Q2 | -25.21 Million EUR | 0.0% |
| 2022 Q4 | -8.58 Million EUR | -54.2% |
| 2022 Q3 | -5.56 Million EUR | 77.92% |
| 2022 FY | -32.08 Million EUR | 47.14% |
| 2021 Q2 | -31.23 Million EUR | 0.0% |
| 2021 Q4 | -29.45 Million EUR | 0.0% |
| 2021 FY | -60.69 Million EUR | 16.34% |
| 2020 Q4 | -35.33 Million EUR | 0.0% |
| 2020 FY | -72.55 Million EUR | -4.6% |
| 2020 Q2 | -37.21 Million EUR | 0.0% |
| 2019 Q4 | -36.14 Million EUR | 0.0% |
| 2019 FY | -69.35 Million EUR | -44.29% |
| 2018 FY | -48.06 Million EUR | -40.33% |
| 2017 FY | -34.25 Million EUR | -30.69% |
| 2016 FY | -26.21 Million EUR | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Nicox S.A. | -17.5 Million EUR | -35.177% |
| European Medical Solutions | -135 Thousand EUR | -17425.926% |
| FERMENTALG | -11.8 Million EUR | -100.373% |
| argenx SE | -417.15 Million EUR | 94.328% |
| BioSenic S.A. | -7.04 Million EUR | -236.08% |
| Celyad Oncology SA | -8.45 Million EUR | -179.768% |
| Hyloris Pharmaceuticals SA | -15.99 Million EUR | -47.94% |
| Onward Medical N.V. | -35.46 Million EUR | 33.283% |
| Oxurion NV | -12.11 Million EUR | -95.376% |
| Financière de Tubize SA | -2.14 Million EUR | -1003.558% |
| UCB SA | 604 Million EUR | 103.917% |